You can buy or sell MTNB and other stocks, options, ETFs, and crypto commission-free!
Matinas BioPharma Holdings, Inc., also called Matinas BioPharma, is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. Read More Its anti-fungal product candidate, MAT2203, delivers broad-spectrum fungicidal agent, amphotericin B; and is being developed to prevent invasive fungal infections in patients with acute lymphoblastic leukemia. The company was founded in May 2013 and is headquartered in Bedminster, NJ.
Bedminster, New Jersey
52 Week High
52 Week Low
Seeking AlphaMay 14
Matinas BioPharma Holdings, Inc. CEO Jerry Jabbour on Q1, 2019 Results - Earnings Call Transcript
Matinas BioPharma Holdings, Inc. Q1 2019 Earnings Conference Call May 14, 2019 8:30 AM ET Company Participants Jenene Thomas - IR Jerry Jabbour - Chief Executive Officer Conference Call Participants Robert Hazlett - BTIG Operator Greetings and welcome to the Matinas BioPharma Quarterly Update Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is...
Matinas BioPharma to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational and Financial Results on May 14, 2019
BEDMINSTER, N.J., May 08, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Tuesday, May 14, 2019 at 8:30 a.m. ET to discuss operational and financial results for the quarter ended March 31, 2019 as well as provide a corporate update. To participate in the call, please dial (877) 407-5976 (domestic) or (412) 902-0031 (international). The live web...
-$0.03 per share
-$0.04 per share